AFCG
Advanced Flower CapitalBDocument history
Earnings documents stored for AFCG.
Investor releaseQuarter not tagged2026-05-08Advanced Flower Capital Inc. Q1 2026 Earnings Call Summary
Moby
Advanced Flower Capital Inc. Q1 2026 Earnings Call Summary
Completed the first quarter operating as a Business Development Company (BDC), expanding investment flexibility beyond real estate-backed cannabis loans. Shifted focus toward the lower middle market to capture an 'exceptional vintage' created by larger lenders moving upmarket to support existing portfolios. Targeting cash-flowing operating businesses with $5 million to $50 million in EBITDA, a segment management believes offers superior risk-adjusted returns. Achieved net fundings of $39.1 million in Q1, driven by $90 million in new non-cannabis commitments offset by $41.2 million in cannabis loan repayments. Emphasizing strong credit quality through the use of financial covenants, such as cash flow measures and fixed charge coverage ratios, rather than the covenant-light structures common in larger deals. Maintaining a robust active pipeline of over $1.5 billion in potential deals across healthcare, consumer, manufacturing, and services sectors. Expects overall portfolio yields to shift toward the low double-digit range as the company prioritizes higher-quality borrowers and sponsors over higher-yielding cannabis assets. Intends to redeploy capital from cannabis loan paydowns and non-accrual liquidations into performing lower middle market credits to support current income. Anticipates that federal rescheduling of cannabis could improve asset values and recovery prospects for non-accrual loans, though the primary growth focus remains non-cannabis lending. Plans to utilize available dry powder and an expanded $80 million credit facility for deployment throughout 2026, though specific timing remains subject to market conditions. Authorized a $5 million share buyback program as a flexible tool for capital allocation and enhancing long-term shareholder value. Reported three loans currently on non-accrual status, with a focus on maximizing recovery through liquidations and legal remedies. Expressed the intention to exercise rights and remedies against Justice Grown following a maturity default on 05/01/2026., targeting collateral including cultivation facilities and dispensaries in New Jersey and Pennsylvania. Received a $6.2 million paydown from the Debbie Holdings receivership during Q1, bringing total recoveries from that credit to $20.8 million. Expanded the senior secured revolving credit facility to $80 million, with a potential accordion feature to reach...
Investor releaseQuarter not tagged2026-05-07Advanced Flower Capital Inc. (AFCG) Q1 Earnings and Revenues Beat Estimates
Zacks
Advanced Flower Capital Inc. (AFCG) Q1 Earnings and Revenues Beat Estimates
Advanced Flower Capital Inc. (AFCG) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.21 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +35.48%. A quarter ago, it was expected that this company would post a loss of $0.04 per share when it actually produced a loss of $0.12, delivering a surprise of -200%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Advanced Flower Capital Inc., which belongs to the Zacks Financial - SBIC & Commercial Industry industry, posted revenues of $9.81 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 36.39%. This compares to year-ago revenues of $6.64 million. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Advanced Flower Capital Inc. shares have lost about 2.8% since the beginning of the year versus the S&P 500's gain of 7.6%. While Advanced Flower Capital Inc. has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Advanced Flower Capital Inc. was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the ma...
Investor releaseQuarter not tagged2026-05-07AFC Gamma Q1 Earnings Call Highlights
MarketBeat
AFC Gamma Q1 Earnings Call Highlights
Interested in AFC Gamma Inc.? Here are five stocks we like better. First quarter operating as a BDC: AFC Gamma shifted into lower middle market private credit, closing two non‑cannabis loans totaling about $90M (plus $5M post‑quarter), reporting net fundings of $39.1M and a deal pipeline of over $1.5B; management expects yields to normalize into the low double‑digit range. Portfolio stress and recovery actions: The firm has three loans on non‑accrual and its Justice Grown loan entered maturity default on May 1, 2026, with AFC pursuing guarantees and asset remedies; it also received $6.2M in Debbie Holt’s paydowns this quarter ( $20.8M total to date). NAV and capital allocation: NAV rose to $7.90 (+$0.44) driven by $0.21 per‑share net investment income and unrealized appreciation; the board declared a $0.05 quarterly dividend, authorized a $5M share buyback, and expanded the revolver to $80M (expandable to $100M). AFC Gamma (NASDAQ:AFCG) reported first-quarter 2026 results and discussed its expanding focus on lower middle market private credit during an earnings call covering the period ended March 31, 2026. Management highlighted the company’s first full quarter operating as a business development company (BDC), new non-cannabis originations, repayments in its cannabis loan book, and updates on certain challenged credits. President and Chief Investment Officer Robyn Tannenbaum said the company completed its “first quarter operating as a BDC,” which she said expanded AFC’s investment flexibility beyond real estate-backed lending. Tannenbaum said the change “better positions AFC to diversify its exposure across industries and credit risk profiles.” → Berkshire Hathaway’s Record Cash Hoard: Why and What's Next? During the quarter, the company closed two non-cannabis lower middle market deals totaling approximately $90 million in new commitments. Tannenbaum also noted that AFC received $41.2 million in cannabis loan repayments during the quarter and posted net fundings of $39.1 million for the period. Daniel Neville, Chief Executive Officer, provided more detail on the quarter’s new investments and additional post-quarter funding. He said AFC closed two loans totaling $90 million during the first quarter and, subsequent to quarter end, “closed an additional $5 million of loans.” → A Prada Payday: Is AMC Back in Style? Neville described a $60 million senior secur...
Investor releaseQuarter not tagged2026-05-07AFC Gamma AFCG Q1 2026 Earnings Call Transcript
Motley Fool
AFC Gamma AFCG Q1 2026 Earnings Call Transcript
Image source: The Motley Fool. Thursday, May 7, 2026 at 10 a.m. ET President — Robyn Tannenbaum Chief Executive Officer — Leonard Mark Tannenbaum Chief Financial Officer — Brandon Hetzel Chief Legal Officer — Gabriel A. Katz Chief Investment Officer — Daniel Neville Robyn providing an overview of our results. Len will then provide commentary on the lower middle market, and then Dan will provide an overview of our portfolio and pipeline. Finally, Brandon will conclude with a summary of our financial results before we open the lines for Q&A. With that, I will now turn the call over to our President, Robyn Tannenbaum. Robyn Tannenbaum: Thanks, Gabe, and good morning, everyone. We appreciate you joining us to discuss Advanced Flower Capital Inc.'s first quarter earnings. Before turning to earnings, we are pleased to have completed our first quarter operating as a BDC. The conversion to a business development company has expanded Advanced Flower Capital Inc.'s investment flexibility, which has allowed us to pursue opportunities beyond real estate-backed loans. We believe that this expanded opportunity better positions Advanced Flower Capital Inc. to diversify its exposure across industries and credit risk profiles. During the quarter, we closed two non-cannabis deals in the lower middle market, totaling approximately $90 million in new commitments. Additionally, we received $41.2 million in cannabis loan repayments during the quarter. For Q1 2026, Advanced Flower Capital Inc. had net fundings of $39.1 million. The two lower middle market deals are similar to other transactions in our pipeline and have many of the characteristics we look for: cash-flowing operating businesses backed by experienced sponsors. Turning to earnings, for the first quarter of 2026, Advanced Flower Capital Inc. generated net investment income of $0.21 per basic weighted average share of common stock. Additionally, the Board of Directors declared a first quarter distribution of $0.05 per share, which was paid on 04/15/2026 to shareholders of record on 03/31/2026. Before turning the call over to Len, I would like to note that the Board of Directors has put a $5 million share buyback program in place. We view the share buyback authorization as a flexible component of our capital allocation strategy designed to enhance long-term shareholder value. Now I will turn it over to Len to discuss the...
Investor releaseQuarter not tagged2026-05-07Advanced Flower Capital Inc. Announces Financial Results for the First Quarter 2026
GlobeNewswire
Advanced Flower Capital Inc. Announces Financial Results for the First Quarter 2026
WEST PALM BEACH, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC,” or the “Company”) today announced its financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights GAAP net investment income (“NII”) for the quarter ended March 31, 2026, was $4.8 million, or $0.21 per basic weighted average share Net asset value per share as of March 31, 2026, was $7.90, as compared to $7.46 as of December 31, 2025 GAAP net increase in net assets resulting from operations for the quarter ended March 31, 2026, was $11.4 million, or $0.49 per basic weighted average share Gross and net investment fundings were $80.9 million and $39.1 million, respectively Net debt-to-equity as of March 31, 2026 was 0.48x “AFC delivered a strong first quarter with net investment income exceeding our quarterly dividend. Additionally, in our first quarter as a BDC, we saw an increase in investment fundings driven by our pipeline focused on the lower-middle market across various industries,” said Dan Neville, Chief Executive Officer. Common Stock Distribution On April 15, 2026, the Company paid a regular cash distribution of $0.05 per common share for the first quarter of 2026 to shareholders of record as of March 31, 2026. Share Repurchase Authorization On May 4, 2026, the Company’s Board authorized a program for the purpose of repurchasing up to $5.0 million of the Company's common stock (the “Repurchase Program”). Under the Repurchase Program, the Company may, but is not obligated to, repurchase its outstanding common stock in the open market from time to time, provided that the Company complies with the prohibitions under its compliance policies and procedures adopted in accordance with the Investment Company Act of 1940, as amended, and the guidelines specified in Rule 10b-18 under the Securities Exchange Act of 1934, as amended, including certain price, market, volume, and timing constraints. Unless amended or extended by the Company's Board of Directors, the Company expects the Repurchase Program to be in place until the later of such time that $5.0 million of the Company's outstanding shares of common stock have been repurchased, or May 4, 2027. Operating Results Additional Information AFC issued a presentation of its first quarter 2026 results, titled “First Quarter 2026 Earnings Presentation,” which can be viewed on...
TranscriptFY2026 Q12026-05-07FY2026 Q1 earnings call transcript
Earnings source - 41 paragraphs
FY2026 Q1 earnings call transcript
Good morning, and welcome to AFC's first quarter 2026 earnings call. At this time, all participants are on a listen-only mode. Later, we will conduct a question and answer session, and instructions will be given at that time. I would now like to turn the call over to Gabriel Katz, Chief Legal Officer. Please go ahead.
Good morning, and thank you all for joining AFC's earnings call for the quarter ended March 31st, 2026. I'm joined this morning by Robyn Tannenbaum, our President and Chief Investment Officer, Leonard Tannenbaum, our Chairman, Daniel Neville, our Chief Executive Officer, and Brandon Hetzel, our Chief Financial Officer. Before we begin, I would like to note that this call is being recorded. Replay information is included in our April 15th, 2026 press release and is posted on the investor relations portion of AFC's website at advancedflowercapital.com, along with our first quarter 2026 earnings release and investor presentation. Today's conference call includes forward-looking statements and projections that reflect the company's current views with respect to, among other things, market developments, anticipated portfolio yield, and financial performance and projections in 2026 and beyond. These statements are subject to inherent uncertainties in predicting future results.
Please refer to AFC's most recent periodic filings with the SEC, including our quarterly report on Form 10-Q, filed earlier this morning, for certain conditions and significant factors that could cause actual results to differ materially from these forward-looking statements and projections. Today's call will begin with Robyn providing an overview of our results. Leonard will then provide commentary on the lower middle market, and then Dan will provide an overview of our portfolio and pipeline. Finally, Brandon will conclude with a summary of our financial results before we open the lines for Q&A. With that, I will now turn the call over to our President, Robyn Tannenbaum.
Thanks, Gabe. Good morning, everyone. We appreciate you joining us to discuss AFC's first quarter earnings. Before turning to earnings, we are pleased to have completed our first quarter operating as a BDC. The conversion to a business development company has expanded AFC's investment flexibility, which has allowed us to pursue opportunities beyond real estate-backed loans. We believe that this expanded opportunity better positions AFC to diversify its exposure across industries and credit risk profiles. During the quarter, we closed two non-cannabis deals in the lower middle market, totaling approximately $90 million in new commitments. We received $41.2 million in cannabis loan repayments during the quarter. For Q1 2026, AFC had net fundings of $39.1 million.
The two lower middle market deals are similar to other potential transactions in our pipeline and have many of the characteristics we look for: cash flow operating businesses backed by experienced sponsors. Turning to earnings, for the first quarter of 2026, AFC generated net investment income of $0.21 per basic weighted average share of common stock. Additionally, the board of directors declared a first quarter distribution of $0.05 per share, which was paid on April 15th, 2026 to shareholders of record on March 31st, 2026. Before turning the call over to Len, I would like to note that the board of directors has put a $5 million share buyback program in place. We view the share buyback authorization as a flexible component of our capital allocation strategy designed to enhance long-term shareholder value.
Now, I'll turn it over to Len to discuss the state of the middle market.
Thank you, Robyn, and good morning, everyone. I want to explain why we are excited about private credit and why we believe the timing is particularly compelling. As private credit experienced meaningful reductions in net inflows, many lenders have exited the lower middle market in favor of moving upmarket to support their existing portfolios. This reduction in capital and resultant shift upmarket has created a sizable opportunity for a small, nimble lender like us to capture what we consider to be an exceptional vintage in the lower middle market. In this part of the market, we are seeing better risk-adjusted returns with absolute yields running at approximately 100 basis points-300 basis points higher than they were just six months ago. Our ideal sweet spot is in the $5 million-$50 million EBITDA range, largely below the threshold where the larger private credit platforms operate.
We believe that the lower middle market assets that we are currently underwriting carry a meaningful distinction from the covenant light structures common in the upper market. Lenders there often rely solely upon a liquidity covenant. Our deals typically include a cash flow measure and a fixed charge coverage ratio covenant. We are not allowing the aggressive EBITDA add backs endemic to larger deals, a further indicator of the strong underlying credit quality opportunity available in the lower middle market. Strategically, we are actively expanding our pipeline and continuing to diversify our portfolio. We believe this vintage offers an attractive opportunity, and we are positioning ourselves to capture it thoughtfully and at scale. I will now turn it over to Dan to discuss the state of our portfolio and our pipeline.
Thanks, Len. I'll begin with an update on our expansion into private credit outside of the cannabis space, followed by an update on our portfolio. As Len described, we feel good about the supply and demand dynamics in lower middle market lending and are excited about the opportunities we are seeing. Since expanding our investable universe, our active pipeline remains strong with over $1.5 billion of deals as of today. We are focused on sourcing deals and backing companies in the lower middle market across a variety of industries, including healthcare, consumer, manufacturing, and services. We are focused on deals where we have expertise or can add value and have no interest in stretching beyond our core competencies. Our sweet spot is providing loans to cash flowing borrowers with $5 million-$50 million of EBITDA.
We are primarily participating in sponsored transactions, though we selectively engage in non-sponsored deals as well. The financings we are looking at are often used for expansion capital, acquisitions, refinancings, or recapitalizations. During Q1, AFC closed two loans totaling $90 million and subsequent to quarter end, AFC closed an additional $5 million of loans. In January, AFC closed on a $60 million senior secured credit facility to support the combination of STAT and The Moresby Group, which is backed by Cambridge Capital. In February, AFC committed $30 million to a $60 million senior secured term loan to support the acquisition and growth of a leading healthcare benefits platform tailored toward hourly and lower wage employees. At closing, AFC funded $20 million of this commitment, and the remaining $10 million was funded subsequent to quarter end.
As I stated last quarter, we currently have three loans on non-approval and are focused on receiving paydowns on these loans to redeploy that capital into performing credits that should contribute to current income. The receiver has continued the liquidation process for our investment in Debbie Holt's. During Q1, we received a $6.2 million paydown, which brings the total paydown since Debbie entered receivership to $20.8 million. Lastly, we wanted to take a minute to touch on Justice Grown. The loan matured on May 1st, 2026 and is in maturity default. Now that the loan has matured, we intend to exercise our rights and remedies under the credit agreement, including our rights under the shareholder guarantee and parent guarantee.
As a reminder, our loan to Justice Grown is secured by the vertical assets in New Jersey, including an own cultivation facility and three dispensaries, two of which are owned. In Pennsylvania, we are secured by three dispensaries and an own cultivation facility, which is currently not operational. We remain laser-focused on pursuing our rights and remedies under the credit agreement and realizing maximum value from this loan. I'll turn it over to Brandon to discuss our financial results in more detail.
Thank you, Dan. For the quarter ended March 31st, 2026, we generated total investment income of $9.8 million and net investment income of $4.8 million or $0.21 per basic weighted average share of common stock. We ended the first quarter of 2026 with $356.6 million of principal outstanding spread across 15 loans. As of May 1st, 2026, our portfolio consisted of $370 million of principal outstanding across 17 loans. As of March 31st, 2026, we had total assets of $394.9 million, total shareholder equity of $185.8 million, and our net asset value per share was $7.90. This is an increase of $0.44 per share over the prior quarter.
The increase in net asset value per share was primarily driven by net investment income of $0.21 per share, an increase in unrealized appreciation on investments of approximately $0.28 per share, offset by the Q1 dividend of $0.05 per share. During the first quarter, AFC expanded its senior secured revolving credit facility to $80 million, with an additional $30 million commitment from the facility's lead arranger an FDIC-insured bank with over $75 billion of assets. The facility remains expandable to $100 million, subject to lender participation in our available borrowing base. During the three months ended March 31st, 2026, we had an average balance drawn on the credit facility of approximately $22 million. Lastly, on April 15th, 2026, we paid the first quarter dividend of $0.05 per common share outstanding to shareholders of record as of March 31st, 2026.
With that, I will now turn it back over to the operator to start the Q&A.
Thank you. Ladies and gentlemen, if you have a question or a comment at this time, please press star one one on your telephone. If your question has been answered and you wish to move yourself from the queue, please press star one one again. We'll pause for a moment while we compile our Q&A roster. Our first question comes from Aaron Grey with AGP. Your line is open.
Hi, thank you for the questions. I guess just first one for me. Thanks for some of the comments you provided on Justice Grown. I guess, how should we think about potential outcomes here, just given the other litigation that is pending? You know, the loan is now officially in default. How should we think about the different potential outcomes that could happen over the near term? Thanks.
Hi, Aaron. I'm gonna pass that one over to our Chief Legal Officer, Gabe.
Sure. Yeah, the loan has matured, as you noted. We are pursuing all rights and remedies to obtain maximum value from the credit facility, but it's too early to make any predictions on outcomes in this litigation.
Okay. Just to clarify, there's still questions in terms of being able to fully take it over, you know, as the other litigation's pending, even if it's currently in default now.
No, we are pursuing our strategies to obtain maximum value from the collateral.
Okay. All right, great. Next question for me, just in terms of some of the incremental, you know, loans in the pipeline. I know you've talked about before some of the expected yields. I understand the April ones were a little bit smaller here, but just wanna, you know, confirm that the ones in the pipeline are expecting similar yields that we have seen kind of that mid to high teens as we go forward for the year.
Hi, Aaron. I'll pass that one to Dan.
Yeah, Aaron, I think, you know, we've got a few loans in our disclosures and you can look at those yield to maturities as a guidepost. I think our overall target and what we've said previously with the transition to lower middle market is that we'd expect the yields to move down a touch into kinda the low double-digit kinda range on an overall basis. Expect the quality of the borrowers, the counterparties on the sponsor side of things, to improve significantly in the lower middle market, generally relative to what's available today across the cannabis landscape.
Mm-hmm. Last question for me, just with the recent rescheduling, you know, currently it's DEA approved in state medical legal operation, does that change your outlook for the cannabis market, or are you still kind of focused in terms of more broadly, maybe less focused on cannabis with pipeline? Thank you.
I think I'll give a little color on the rescheduling side of things. I think it's great to see progress at the federal level finally after five years. I think the positives are it eliminates 280E liabilities for medical operators today. It certainly eliminates future uncertainty or decreases future uncertainty related to go-forward liabilities, given the path that we seem to be on at the federal level, with hearings related to adult use later this year as well. You have potential relief of historical tax liabilities, at least for medical operators as was highlighted in the actions over the last few weeks. That, the combination of those factors could potentially attract additional capital over time.
I think the negatives are that none of the operators were really paying taxes today outside of, outside of GTI. If you look at the cash flow statements for the last couple of years, that reflects a post 280E world on a cash basis today. Certainly I think the industry is more competitive than it was five years ago. The relief came, but it took a long time to get here. I think the consequences of that are that to the extent that additional capital is attracted to the industry, that would be positive for asset values, that would be positive for medical asset values, certainly given that 280E is eliminated, and it could lead to better realizations for us on loans that we have on non-accrual.
We are seeing better opportunities in the lower middle market today, given the economics that we're seeing, the less competitive nature of the lending environment in the lower middle market today generally, and the quality of the borrowers and counterparties. I think on a go-forward basis, while rescheduling is great and it could be good for asset values and our loans on non-accrual, we are still focused on expanding into the lower middle market lending generally.
Okay, great. Really helpful color there. I'll jump back in the queue.
Thank you. One moment for our next question. Our next question comes from Pablo Zuanic with Zuanic & Associates. Your line is open.
Yes, good morning, everyone. Look, you gave some color on the two large loans that you made in the first quarter to the non-cannabis companies. Can you expand a little bit more? I mean, these are private companies. We don't have access to their financials. Whatever additional color you can provide to understand better what those companies are doing, what their plans are for those proceeds from the loans, that would be helpful. Thank you.
Sure, Pablo. Yes, as you mentioned, they are private companies. That's, you know, the vast majority of loans that are done in the BDC space are to private companies. We can give a little bit of color here on two of those businesses. STAT, we put out a press release on that described what the business does. They operate in the revenue recovery space, related to suppliers into big retailers like Walmart, Target, the Amazon ecosystem, et cetera. They recover deductions related to invoices for goods that are shipped into Walmart and those other retailers. If you think about the opportunity set there, you know, Walmart has $700 billion of sales. Their cost of goods sold is probably somewhere around $400 billion.
Every invoice that goes into Walmart, you typically see a 2% deduction related to various issues with quantity mismatches on time in full, et cetera. These folks will work to recover that, which is, you know, an $8 billion opportunity on that 10% for Walmart alone. You expand that opportunity as you get to other retailers on the platform. The use of proceeds there was for a refinancing of an existing credit facility on the buyer as well as to partially finance the acquisition of The Moresby Group. On BCIS borrower, that's as we've discussed, a healthcare benefits platform that serves low-wage employees. You know, when I in my previous life, you know, I had 1,700 hourly employees who dealt with benefits there.
One of the constant complaints was that regular way healthcare insurance was way too expensive, non-affordable, and honestly overkill for, you know, folks in the 18-35 age subset. This product provides a low-cost offering for virtual urgent care, primary care, generic prescriptions, and is good for the employee. It's a low-cost option and good for the employer as an avenue for some tax savings on FICA payroll taxes. The platform is seeing tremendous growth and is really attacking an interesting niche and unfilled need in the healthcare insurance market.
Thank you. That's a great color. My last question, obviously I can do the math, but you have the cash on the balance sheet that you reported for end of March plus the expanded credit facility. If I put all that together, do you think you can deploy all of that this year? I mean, you've talked about the pipeline, but just trying to think how we should model book loan growth from here to end of the year. Thanks.
Pablo, it's Robyn. I think that as we're entering the lower middle market, it's hard to predict and give any guidance as to the rest of the year as to what we're going to fund. We do have dry powder that we look to deploy over the course of the year. As we get repayments, as we discussed this quarter, we'll look to deploy that capital as well.
Yeah, that's good. Thank you.
Thank you.
I'm not showing any further questions at this time. I'd like to turn the call back over to CEO Daniel Neville for any further remarks.
Thank you for joining us this morning, and we look forward to updating you on our continued transition to lower middle market lending on future calls.
Thank you, ladies and gentlemen. This does conclude today's presentation. We thank you for your participation. You may now disconnect and have a wonderful day.
Investor releaseQuarter not tagged2026-04-15AFC Schedules Earnings Release and Conference Call for the First Quarter Ended March 31, 2026
GlobeNewswire
AFC Schedules Earnings Release and Conference Call for the First Quarter Ended March 31, 2026
WEST PALM BEACH, Fla., April 15, 2026 (GLOBE NEWSWIRE) -- AFC today announced that it will release its financial results for the first quarter ended March 31, 2026, on Thursday, May 7, 2026, before market open. Management will review AFC’s financial results at 10:00 am ET via webcast available on the Investor Relations section of AFC’s website found here AFC -- Investor Relations. Participants are also invited to access the conference call by registering in advance at this link. A replay will be available one hour after the event. AFC distributes its earnings releases via its website and email lists. Those interested in receiving firm updates by email can sign up for them here. About AFC AFC (Nasdaq: AFCG) is a publicly traded business development company that provides flexible credit solutions to lower middle market companies. The company primarily originates, structures, invests and manages direct senior debt investments typically ranging from $10 to $100 million. The company seeks to maximize risk-adjusted returns for its stockholders with an opportunistic approach across all industries. AFC is headquartered in West Palm Beach, Florida. For additional information regarding the company, please visit the AFC website here. Investor Relations Contact Robyn Tannenbaum 561-510-2293 [email protected]
Investor releaseQuarter not tagged2026-04-02Advanced Flower Capital Inc. (AFCG) Reports Financial Results for the Fourth Quarter and Full Year 2025
Insider Monkey
Advanced Flower Capital Inc. (AFCG) Reports Financial Results for the Fourth Quarter and Full Year 2025
Advanced Flower Capital Inc. (NASDAQ:AFCG) is one of the 11 Best Marijuana Stocks to Buy Right Now. On March 4, 2026, Advanced Flower Capital Inc. (NASDAQ:AFCG) reported fourth-quarter 2025 GAAP net income of $0.9 million, or $0.04 per share, with distributable earnings of $(2.8) million, or ($0.12) per share. The corporation announced a full-year GAAP net loss of $(20.7) million, or $0.95 per share, while producing distributable earnings of $8.7 million, or $0.39 per share. Advanced Flower Capital Inc. (NASDAQ:AFCG)’s CEO, Dan Neville, stated that the company focused on disciplined portfolio management and completed its BDC conversion in 2025 by resolving underperforming loans and reallocating capital to lower-middle-market enterprises. On March 2, 2026, the firm declared a cash dividend of $0.05 per common share for the first quarter of 2026, which will be paid on April 15, 2026, to shareholders of record as of March 31, 2026. Advanced Flower Capital Inc. (NASDAQ:AFCG) offers commercial real estate finance services. Its primary business is to originate, structure, underwrite, and manage senior secured loans and other types of loans for established businesses in the cannabis market across states. While we acknowledge the potential of AFCG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Disclosure: None. Follow Insider Monkey on Google News.
Investor releaseQuarter not tagged2026-03-05Advanced Flower Capital Inc (AFCG) Q4 2025 Earnings Call Highlights: Strategic Transition to ...
GuruFocus.com
Advanced Flower Capital Inc (AFCG) Q4 2025 Earnings Call Highlights: Strategic Transition to ...
This article first appeared on GuruFocus. Release Date: March 04, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Advanced Flower Capital Inc (NASDAQ:AFCG) successfully converted from a real estate investment trust to a business development company (BDC), expanding its investment flexibility. The company received $117 million in paydowns from both performing and underperforming credits, indicating effective portfolio management. AFCG originated $53 million in new commitments during 2025 and closed on $89.7 million of new commitments in the lower middle market after year-end. The active pipeline increased significantly to $1.4 billion, reflecting the expanded investment universe post-conversion to a BDC. AFCG closed two significant loans in Q1 2026, including a $60 million senior secured credit facility and a $30 million senior secured term loan, supporting growth in diverse industries. AFCG reported distributable earnings per share of negative $0.12 for the quarter, primarily due to losses from underperforming credits. The company has three loans on non-accrual status, which could continue to affect earnings and recovery value. AFCG's GAAP net loss for the full year 2025 was $20.7 million, indicating financial challenges. The company faces difficulties in deploying fresh capital into the cannabis sector due to regulatory and financial challenges within the industry. AFCG's capacity to sustain a $100 million per quarter lending pace is uncertain, given current credit facilities and cash on hand. Warning! GuruFocus has detected 3 Warning Signs with AFCG. Is AFCG fairly valued? Test your thesis with our free DCF calculator. Q: The active pipeline increased significantly to $1.4 billion from last quarter's $400 million. What factors contributed to this increase, and how quickly could this translate to closed originations? A: The increase is primarily due to our conversion from a REIT to a BDC, which expanded our investable universe beyond cannabis and real estate-backed loans. This allows us to invest in cash flow loans not fully covered by real estate, broadening our opportunities. Q: Can you provide a split between the cannabis and non-cannabis pipeline, and how do the expected yields for non-cannabis compare to the legacy portfolio? A: We view the active pipeline as spanning lower middle market compani...
Investor releaseQuarter not tagged2026-03-05Advanced Flower Capital Inc. Q4 2025 Earnings Call Summary
Moby
Advanced Flower Capital Inc. Q4 2025 Earnings Call Summary
Completed conversion from a REIT to a Business Development Company (BDC) as of January 1, 2026, to remove real estate coverage restrictions and expand the investable universe. Focused 2025 efforts on reducing exposure to underperforming credits to preserve capital, with $117,000,000 in total paydowns received from early 2025 through the reporting date. Shifted strategic focus toward the lower middle market, targeting cash-flowing borrowers with EBITDA between $5,000,000 and $50,000,000 across diverse industries. Attributed 2025 distributable earnings pressure primarily to realized losses from two underperforming credits, resulting in dividends being characterized as a tax-free return of capital. Maintained a high bar for new cannabis investments due to a lack of industry equity capital, burgeoning tax liabilities, and slow incremental progress on regulatory reforms. Actively managing three nonaccrual loans with the intent to redeploy recovered capital into performing credits to unlock future earnings potential. Identified an active deal pipeline of over $1,400,000,000 as of February 2026, a significant increase driven by the expanded BDC investment mandate. Anticipates continued distributions from Private Company A throughout 2026 as operating assets under agreement meet regulatory milestones. Expects the sale of all collateral for Private Company K to be completed within 2026, with two dispensaries currently awaiting regulatory approval for sale. Management is evaluating options to refinance $77,000,000 in unsecured bonds prior to their May 2027 maturity date. Future dividend characterization may continue as a return of capital if additional losses are recognized during the 2026 fiscal year. Recorded a CECL reserve of $46,100,000, representing approximately 18.2% of loans at carrying value as of year-end 2025. Recognized a total unrealized loss of $27,700,000 on the balance sheet for loans held at fair value. Repurchased $13,000,000 of unsecured bonds during the quarter to manage the company's debt profile. Noted the upcoming maturity of the Justice Grown loan on May 1, 2026, amid ongoing legal appeals regarding a preliminary injunction. Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Management attributed the growth to the BDC conversion, which allows f...
Investor releaseQuarter not tagged2026-03-05Advanced Flower Capital (AFCG) Earnings Transcript
Motley Fool
Advanced Flower Capital (AFCG) Earnings Transcript
Image source: The Motley Fool. Wednesday, March 4, 2026 at 10 a.m. ET Chief Executive Officer — Daniel Neville Chief Financial Officer — Brandon Hetzel President and Chief Investment Officer — Robyn Tannenbaum Daniel Neville, our Chief Executive Officer; and Brandon Hetzel, our Chief Financial Officer. Before we begin, I would like to note that this call is being recorded. Replay information is included in our 02/10/2026 press release and is posted on the Investor Relations portion of Advanced Flower Capital Inc.'s website at advancedflowercapital.com, along with our fourth quarter and full year earnings release and investor presentation. Today's conference call includes forward-looking statements and projections that reflect the company's current views with respect to, among other things, anticipated market developments, portfolio yield, and financial performance in 2026 and beyond. These statements are subject to inherent uncertainties in predicting future results. Please refer to Advanced Flower Capital Inc.'s most recent periodic filings with the SEC, including our Annual Report on Form 10-K filed earlier this morning, for certain conditions and significant factors that could cause actual results to differ materially from these forward-looking statements and projections. During this call, we will refer to distributable earnings, which is a non-GAAP financial measure. Reconciliations to net income, the most comparable GAAP measure, for distributable earnings can be found in Advanced Flower Capital Inc.'s earnings release and investor presentation available on our website. Today's call will begin with Robyn providing a high-level recap of our 2025 fiscal year, including the conversion to a BDC. Dan will then provide an overview of our portfolio. Finally, Brandon will conclude with a summary of our financial results before we open the lines for Q&A. With that, I will now turn the call over to our President and CIO, Robyn Tannenbaum. Robyn Tannenbaum: Thanks, Gabe, and good morning to all our investors and analysts that have joined us today. Looking back on 2025, Advanced Flower Capital Inc. was focused on, one, reducing our exposure to underperforming credits through active portfolio management, and two, converting from a real estate trust to a business development company, or BDC, to expand the universe of transactions Advanced Flower Capital Inc. could in...
Investor releaseQuarter not tagged2026-03-05AFC Gamma Q4 Earnings Call Highlights
MarketBeat
AFC Gamma Q4 Earnings Call Highlights
Converted to a BDC (effective Jan. 1, 2026), broadening AFC Gamma’s investment mandate beyond real-estate-backed loans to cash-flow lending; management says the active pipeline exceeds $1.4 billion and the company has already closed sizable lower-middle-market deals, including a $60 million facility and a $30 million commitment in early 2026. AFC spent 2025 on credit remediation, receiving about $117 million of paydowns while still carrying three loans on non-accrual and a CECL reserve of $46.1 million (≈18.2% of loans), with ongoing recovery efforts in legacy positions (Private Company A/K and Justice Grown) expected to drive further distributions. Financially, Q4 distributable earnings were -$2.8 million (GAAP net income $0.9M) while full-year 2025 showed distributable earnings of $8.7 million but a GAAP net loss of $20.7 million; the board declared a $0.05 per share first-quarter dividend payable April 15, 2026. Interested in AFC Gamma Inc.? Here are five stocks we like better. Advanced Flower Capital’s leadership said the company spent 2025 actively managing underperforming credits, generating meaningful loan paydowns, and preparing for a strategic shift that broadened its investment universe. On the company’s fourth-quarter and full-year 2025 earnings call, executives also discussed the completion of a conversion from a REIT to a business development company (BDC) effective Jan. 1, 2026, along with early activity under the expanded lending mandate. Robyn Tannenbaum, President and Chief Investment Officer of AFC Gamma (NASDAQ:AFCG), said the company’s focus during 2025 centered on reducing exposure to underperforming credits through active portfolio management and completing the conversion from a REIT to a BDC to expand the universe of transactions it can pursue. → IonQ in Rebound Mode: Buy the Thesis, Respect the Risk Tannenbaum said AFC received $117 million of paydowns from performing and underperforming credits from the start of 2025 through the date of the call. She also said the company originated $53 million of new commitments during fiscal 2025 and, subsequent to year-end, closed $89.7 million of new commitments in the lower middle market. Management framed the paydowns and redeployment effort as an opportunity to improve earnings power over time, noting that repayments from underperforming assets could be reinvested into performing credits. → Bi...

